Isolation, Structural Characterization and Evaluation of <i>in-vitro</i> Anti-tubercular Activity of Quercetin from Leaves of <i>Tragia involucrata</i>

Tragia involucrata L., a member of the Euphorbiaceae family has been traditionally utilized for the treatment of bronchitis, leprosy and various skin diseases. Tuberculosis (TB) caused by Mycobacterium tuberculosis, remains a significant global health threat, exacerbated by the increasing prevalence of Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) strains. This study explores the anti-tubercular potential of T. involucrata Linn, a plant known for its historical use in managing respiratory conditions, by isolating the bioactive flavonoid quercetin from its Hydroalcoholic Leaf Extract (HALET). The leaves of the plant material were extracted using 70:30 (water: ethanol) and isolated using column chromatography, with mobile phases composed of hexane-ethyl acetate and a chloroform-methanol-water mixture, gradually increasing in solvent polarity and flavonoid content was estimated. Quercetin was identified in HALET through High-Performance Thin-Layer Chromatography (HPTLC) fingerprinting. The isolated quercetin was characterized using UV, Infrared (IR), Nuclear Magnetic Resonance (NMR) and Liquid Chromatography-Mass Spectrometry (LC-MS) spectral techniques. In-vitro anti-tubercular activity of both the HALET and the isolated quercetin was assessed using the Alamar blue dye Assay against M. tuberculosis H37Rv. The results indicated a Minimum Inhibitory Concentration (MIC) of 3.12 µg/mL for isolated quercetin and 6.25 µg/mL for HALET. These findings suggest that both the extract and quercetin exhibit significant anti-tubercular activity, comparable to the efficacy of standard drugs. Major Findings: This study highlights the potential of T. involucrata and its active flavonoids as promising, cost-effective and safer alternatives to conventional anti-tubercular treatments, particularly in the context of drug-resistant TB.

View article page

Download PDF